Researchers found differences in polymerase chains thought to be similar, potentially opening new pathways toward cancer drug development.
Molecular events that form such “reward memories” appear to differ from those created by drug addiction, despite the popular theory that addiction hijacks normal reward pathways.
Discovery leads researchers to redouble efforts to design a new class of drugs to treat diabetes.
Researchers show long-term efficacy of the first FDA approved drug for vasculitis.
The new Viral Hepatitis Clinic offers patients the latest therapies and follows the treatment model in HIV care pioneered by the 1917 Clinic.
The Division of Neurosurgery’s 15 residents to published 75 articles in peer-reviewed medical journals last year.
As part of a UAB study, physicians are completing a survey on their understanding of patient attitudes and misperceptions about generic medications.
Originally built in 1975, the Wallace Tumor Institute is the hub of the Comprehensive Cancer Center’s research and administrative enterprise.